title: Highly sensitive C-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and an acute coronary event.
abstract: Patients with metabolic syndrome are at high-risk for development of atherosclerosis and cardiovascular events. The objective of this study was to examine the major determinants of coronary disease severity, including those coronary risk factors associated with metabolic syndrome, during the early period after an acute coronary episode. We tested the hypothesis that inflammatory markers, especially highly sensitive C-reactive protein (hsCRP), are related to coronary atherosclerosis, in addition to traditional coronary risk factors. Subjects of both genders aged 30 to 75 years (N = 116) were prospectively included if they had suffered a recent acute coronary syndrome (acute myocardial infarction or unstable angina pectoris requiring hospitalization) and if they had metabolic syndrome diagnosed according to the National Cholesterol Education Program/Adult Treatment Panel III. Patients were submitted to a coronary angiography and the burden of atherosclerosis was estimated by the Gensini score. The severity of coronary disease was correlated (Spearman's or Pearson's coefficient) with gender (r = 0.291, P = 0.008), age (r = 0.218, P = 0.048), hsCRP (r = 0.256, P = 0.020), ApoB/ApoA ratio (r = 0.233, P = 0.041), and carotid intima-media thickness (r = 0.236, P = 0.041). After multiple linear regression, only male gender (P = 0.046) and hsCRP (P = 0.012) remained independently associated with the Gensini score. In this high-risk population, male gender and high levels of hsCRP, two variables that can be easily obtained, were associated with more extensive coronary disease, identifying patients with the highest potential of developing new coronary events.
authors.affiliation: Universidade Federal de São Paulo, SP, Brasil.
authors.forename: C M C
authors.initials: CM
authors.lastname: Monteiro
authors.forename: L F
authors.initials: LF
authors.lastname: Pinheiro
authors.forename: M C
authors.initials: MC
authors.lastname: Izar
authors.forename: S W
authors.initials: SW
authors.lastname: Barros
authors.forename: M B
authors.initials: MB
authors.lastname: Vasco
authors.forename: S M
authors.initials: SM
authors.lastname: Fischer
authors.forename: R M
authors.initials: RM
authors.lastname: Povoa
authors.forename: S A
authors.initials: SA
authors.lastname: Brandão
authors.forename: A O
authors.initials: AO
authors.lastname: Santos
authors.forename: L
authors.initials: L
authors.lastname: Oliveira
authors.forename: A C
authors.initials: AC
authors.lastname: Carvalho
authors.forename: F A H
authors.initials: FA
authors.lastname: Fonseca
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood* / Q000209:etiology; D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D017023:Coronary Angiography; D005260:Female; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood* / Q000150:complications; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012737:Sex Factors
chemical_list: D015415:Biomarkers; D002097:C-Reactive Protein